Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Gemcitabine and docetaxel combination chemotherapy for advanced bone and soft tissue sarcomas: protocol for an open-label, non-randomised, Phase 2 study ; volume:19 ; number:1 ; day:23 ; month:7 ; year:2019 ; pages:1-6 ; date:12.2019
BMC cancer ; 19, Heft 1 (23.7.2019), 1-6, 12.2019
- Urheber
-
Hara, Hitomi
Kawamoto, Teruya
Fukase, Naomasa
Kawakami, Yohei
Takemori, Toshiyuki
Fujiwara, Shuichi
Kitayama, Kazumichi
Nishida, Kotaro
Kuroda, Ryosuke
Akisue, Toshihiro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-5923-7
- URN
-
urn:nbn:de:101:1-2019121708182992508903
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hara, Hitomi
- Kawamoto, Teruya
- Fukase, Naomasa
- Kawakami, Yohei
- Takemori, Toshiyuki
- Fujiwara, Shuichi
- Kitayama, Kazumichi
- Nishida, Kotaro
- Kuroda, Ryosuke
- Akisue, Toshihiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306
Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Gemcitabine and Docetaxel for Epithelioid Sarcoma : Results from a Retrospective, Multi-Institutional Analysis
Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
Imaging of Bone Sarcomas and Soft-Tissue Sarcomas
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy
A rare presentation of carcinosarcoma of the bone in a young female; response with gemcitabine and docetaxel
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments
A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306
Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Gemcitabine and Docetaxel for Epithelioid Sarcoma : Results from a Retrospective, Multi-Institutional Analysis
Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
Imaging of Bone Sarcomas and Soft-Tissue Sarcomas
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy
A rare presentation of carcinosarcoma of the bone in a young female; response with gemcitabine and docetaxel
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments
A phase II study of gemcitabine and docetaxel combination in relapsed metastatic or unresectable locally advanced synovial sarcoma
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306
Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Gemcitabine and Docetaxel for Epithelioid Sarcoma : Results from a Retrospective, Multi-Institutional Analysis
Gemcitabine and Docetaxel for Epithelioid Sarcoma: Results from a Retrospective, Multi-Institutional Analysis
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
Imaging of Bone Sarcomas and Soft-Tissue Sarcomas
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
Other rare sarcomas, mixed tumors, genital sarcomas and pregnancy
A rare presentation of carcinosarcoma of the bone in a young female; response with gemcitabine and docetaxel
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments